Macquarie Maintains Outperform on Imax, Raises Price Target to $48

Benzinga Newsdesk www.benzinga.com Positive 88.2%

Neg 0% Neu 0% Pos 88.2%

Macquarie analyst Chad Beynon maintains Imax (NYSE:IMAX) with a Outperform and raises the price target from $46 to $48.

Comments

No comments yet. Be the first!